{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:44:32Z","timestamp":1790192672514,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370285"],"award-info":[{"award-number":["81370285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970206"],"award-info":[{"award-number":["81970206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["2019A1515010269"],"award-info":[{"award-number":["2019A1515010269"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou City Science and Technology key Program","award":["201508020057"],"award-info":[{"award-number":["201508020057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s40256-020-00435-9","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T01:02:43Z","timestamp":1601514163000},"page":"299-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs"],"prefix":"10.1007","volume":"21","author":[{"given":"Zi-Heng","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Cheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Jiu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Zhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"issue":"2","key":"435_CR1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrcardio.2016.173","volume":"14","author":"E Guasch","year":"2017","unstructured":"Guasch E, Mont L. Diagnosis, pathophysiology, and management of exercise-induced arrhythmias. Nat Rev Cardiol. 2017;14(2):88\u2013101.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"435_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00006205-199805000-00003","volume":"23","author":"DD Chrzanowski","year":"1998","unstructured":"Chrzanowski DD. Managing AF to prevent its major complication: ischemic stroke. Nurse Pract. 1998;23(5):26.","journal-title":"Nurse Pract."},{"issue":"2","key":"435_CR3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10840-017-0308-9","volume":"51","author":"P Rattanawong","year":"2018","unstructured":"Rattanawong P, Upala S, Riangwiwat T, Jaruvongvanich V, Sanguankeo A, Vutthikraivit W, Chung EH. AF is associated with sudden cardiac death: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2018;51(2):91\u2013104.","journal-title":"J Interv Card Electrophysiol"},{"key":"435_CR4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","volume":"32","author":"DL Dries","year":"1998","unstructured":"Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. AF is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials: studies of left ventricular dysfunction. J Am Coll Cardiol. 1998;32:695\u2013703.","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"435_CR5","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of AF developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962.","journal-title":"Eur Heart J"},{"issue":"1","key":"435_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/CIRCEP.113.000586","volume":"7","author":"JG Andrade","year":"2014","unstructured":"Andrade JG, Khairy P, Macle L, Packer DL, Lehmann JW, Holcomb RG, Ruskin JN, Dubuc M. Incidence and significance of early recurrences of AF after cryoballoon ablation. Circ Arrhythm Electrophysiol. 2014;7(1):69\u201375.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"6","key":"435_CR7","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0735-1097(01)01214-1","volume":"37","author":"G Stabile","year":"2001","unstructured":"Stabile G, De Simone A, Turco P, La Rocca V, Nocerino P, Astarita C, Maresca F, De Matteis C, Di Napoli T, Stabile E, Vitale DF. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with AF. J Am Coll Cardiol. 2001;37(6):1639\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"435_CR8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","volume":"27","author":"G Stabile","year":"2006","unstructured":"Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF. Catheter ablation treatment in patients with drug-refractory AF: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for The Cure Of AF Study). Eur Heart J. 2006;27(2):216\u201321.","journal-title":"Eur Heart J"},{"issue":"1","key":"435_CR9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","volume":"20","author":"GB Forleo","year":"2009","unstructured":"Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S, De Sanctis V, Pappalardo A, Laurenzi F, Avella A, Casella M, Dello Russo A, Romeo F, Pelargonio G, Tondo C. Catheter ablation of AF in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20(1):22\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"435_CR10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1540-8167.2011.02010.x","volume":"22","author":"R Parkash","year":"2011","unstructured":"Parkash R, Tang AS, Sapp JL, Wells G. Approach to the catheter ablation technique of paroxysmal and persistent atrial fibrillation: a meta-analysis of the randomized controlled trials. J Cardiovasc Electrophysiol. 2011;22(7):729\u201338.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"435_CR11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCEP.114.001853","volume":"7","author":"AR Khan","year":"2014","unstructured":"Khan AR, Khan S, Sheikh MA, Khuder S, Grubb B, Moukarbel GV. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014;7(5):853\u201360.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"435_CR12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/europace\/euu376","volume":"17","author":"A Hakalahti","year":"2015","unstructured":"Hakalahti A, Biancari F, Nielsen JC, Raatikainen MJ. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Europace. 2015;17(3):370\u20138.","journal-title":"Europace."},{"issue":"30","key":"435_CR13","doi-asserted-by":"crossref","first-page":"e4377","DOI":"10.1097\/MD.0000000000004377","volume":"95","author":"M Zhu","year":"2016","unstructured":"Zhu M, Zhou X, Cai H, Wang Z, Xu H, Chen S, Chen J, Xu X, Xu H, Mao W. Catheter ablation versus medical rate control for persistent atrial fibrillation in patients with heart failure: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95(30):e4377.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"435_CR14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00059-015-4372-6","volume":"41","author":"B Zhang","year":"2016","unstructured":"Zhang B, Shen D, Feng S, Zhen Y, Zhang G. Efficacy and safety of catheter ablation vs. rate control of atrial fibrillation in systolic left ventricular dysfunction: a meta-analysis and systematic review. Herz. 2016;41(4):342\u201350.","journal-title":"Herz."},{"issue":"1","key":"435_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-018-0349-8","volume":"52","author":"C Chen","year":"2018","unstructured":"Chen C, Zhou X, Zhu M, Chen S, Chen J, Cai H, Dai J, Xu X, Mao W. Catheter ablation versus medical therapy for patients with persistent AF: a systematic review and meta-analysis of evidence from randomized controlled trials. J Interv Card Electrophysiol. 2018;52(1):9\u201318.","journal-title":"J Interv Card Electrophysiol"},{"issue":"4","key":"435_CR16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","volume":"303","author":"DJ Wilber","year":"2010","unstructured":"Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal AF: a randomized controlled trial. JAMA. 2010;303(4):333\u201340.","journal-title":"JAMA"},{"issue":"24","key":"435_CR17","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","volume":"118","author":"P Ja\u00efs","year":"2008","unstructured":"Ja\u00efs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Cl\u00e9menty J, Ha\u00efssaguerre M. Catheter ablation versus antiarrhythmic drugs for AF: the A4 study. Circulation. 2008;118(24):2498\u2013505.","journal-title":"Circulation"},{"key":"435_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0693","author":"DL Packer","year":"2019","unstructured":"Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappat R, Kuck K-H, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL, for the CABANA Investigators. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. The CABANA randomized clinical trial. JAMA. 2019. https:\/\/doi.org\/10.1001\/jama.2019.0693(published online March 15, 2019).","journal-title":"JAMA"},{"key":"435_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0692","author":"DB Mark","year":"2019","unstructured":"Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, Daniels MR, Bahnson TD, Poole JE, Rosenberg Y, Lee KL, Packer DL, For the CABANA Investigators. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019. https:\/\/doi.org\/10.1001\/jama.2019.0692(published online March 15, 2019).","journal-title":"JAMA"},{"issue":"5","key":"435_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, B\u00e4nsch D, CASTLE-AF Investigators. Catheter ablation for AF with heart failure. N Engl J Med. 2018;378(5):417\u201327.","journal-title":"N Engl J Med."},{"issue":"16","key":"435_CR21","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","volume":"70","author":"S Prabhu","year":"2017","unstructured":"Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Gutman SJ, Lee G, Layland J, Mariani JA, Ling LH, Kalman JM, Kistler PM. Catheter ablation versus medical rate control in AF and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol. 2017;70(16):1949\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"435_CR22","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2016.10.037","volume":"68","author":"H Sohara","year":"2016","unstructured":"Sohara H, Ohe T, Okumura K, Naito S, Hirao K, Shoda M, Kobayashi Y, Yamauchi Y, Yamaguchi Y, Kuwahara T, Hirayama H, YeongHwa C, Kusano K, Kaitani K, Banba K, Fujii S, Kumagai K, Yoshida H, Matsushita M, Satake S, Aonuma K. HotBalloon ablation of the pulmonary veins for paroxysmal AF: a multicenter randomized trial in Japan. J Am Coll Cardiol. 2016;68(25):2747\u201357.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"435_CR23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.hrthm.2016.12.023","volume":"14","author":"E Bertaglia","year":"2017","unstructured":"Bertaglia E, Senatore G, De Michieli L, De Simone A, Amellone C, Ferretto S, La Rocca V, Giuggia M, Corrado D, Zoppo F, Stabile G. Twelve-year follow-up of catheter ablation for AF: a prospective, multicenter, randomized study. Heart Rhythm. 2017;14(4):486\u201392.","journal-title":"Heart Rhythm"},{"issue":"17","key":"435_CR24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","volume":"133","author":"L Di Biase","year":"2016","unstructured":"Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A. Ablation versus amiodarone for treatment of persistent AF in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637\u201344.","journal-title":"Circulation"},{"key":"435_CR25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2015.06.160","volume":"198","author":"MJ Raatikainen","year":"2015","unstructured":"Raatikainen MJ, Hakalahti A, Uusimaa P, Nielsen JC, Johannessen A, Hindricks G, Walfridsson H, Pehrson S, Englund A, Hartikainen J, Kongstad O, Mortensen LS, Hansen PS, MANTRA-PAF investigators. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal AF: on-treatment analysis of the randomized controlled MANTRA-PAF trial. Int J Cardiol. 2015;198:108\u201314.","journal-title":"Int J Cardiol."},{"issue":"2","key":"435_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/europace\/euu342","volume":"17","author":"H Walfridsson","year":"2015","unstructured":"Walfridsson H, Walfridsson U, Nielsen JC, Johannessen A, Raatikainen P, Janzon M, Levin LA, Aronsson M, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Radiofrequency ablation as initial therapy in paroxysmal AF: results on health-related quality of life and symptom burden. The MANTRA-PAF trial. Europace. 2015;17(2):215\u201321.","journal-title":"Europace"},{"issue":"20","key":"435_CR27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurheartj\/ehu017","volume":"35","author":"XD Zhang","year":"2014","unstructured":"Zhang XD, Gu J, Jiang WF, Zhao L, Zhou L, Wang YL, Liu YG, Liu X. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent AF: a randomized clinical trial. Eur Heart J. 2014;35(20):1327\u201334.","journal-title":"Eur Heart J"},{"issue":"1","key":"435_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","volume":"7","author":"RJ Hunter","year":"2014","unstructured":"Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, Goromonzi F, Sawhney V, Duncan E, Page SP, Ullah W, Unsworth B, Mayet J, Dhinoja M, Earley MJ, Sporton S, Schilling RJ. A randomized controlled trial of catheter ablation versus medical treatment of AF in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7(1):31\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"435_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.hrthm.2013.11.009","volume":"11","author":"J Hummel","year":"2014","unstructured":"Hummel J, Michaud G, Hoyt R, DeLurgio D, Rasekh A, Kusumoto F, Giudici M, Dan D, Tschopp D, Calkins H, Boersma L, TTOP-AF Investigators. Phased RF ablation in persistent AF. Heart Rhythm. 2014;11(2):202\u20139.","journal-title":"Heart Rhythm."},{"issue":"8","key":"435_CR30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","volume":"35","author":"L Mont","year":"2014","unstructured":"Mont L, Bisbal F, Hern\u00e1ndez-Madrid A, P\u00e9rez-Castellano N, Vi\u00f1olas X, Arenal A, Arribas F, Fern\u00e1ndez-Lozano I, Bodegas A, Cobos A, Mat\u00eda R, P\u00e9rez-Villacast\u00edn J, Guerra JM, \u00c1vila P, L\u00f3pez-Gil M, Castro V, Arana JI, Brugada J, SARA Investigators. Catheter ablation vs. antiarrhythmic drug treatment of persistent AF: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501\u20137.","journal-title":"Eur Heart J."},{"issue":"17","key":"435_CR31","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","volume":"367","author":"J Cosedis Nielsen","year":"2012","unstructured":"Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Radiofrequency ablation as initial therapy in paroxysmal AF. N Engl J Med. 2012;367(17):1587\u201395.","journal-title":"N Engl J Med"},{"issue":"6","key":"435_CR32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCEP.111.966408","volume":"4","author":"C Pappone","year":"2011","unstructured":"Pappone C, Vicedomini G, Augello G, Manguso F, Saviano M, Baldi M, Petretta A, Giannelli L, Calovic Z, Guluta V, Tavazzi L, Santinelli V. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ Arrhythm Electrophysiol. 2011;4(6):808\u201314.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"435_CR33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCOUTCOMES.110.957563","volume":"3","author":"MR Reynolds","year":"2010","unstructured":"Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of life in patients with paroxysmal AF treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes. 2010;3(6):615\u201323.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"435_CR34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12882-017-0621-7","volume":"18","author":"IN van Loon","year":"2017","unstructured":"van Loon IN, Bots ML, Boereboom FTJ, Grooteman MPC, Blankestijn PJ, van den Dorpel MA, Nub\u00e9 MJ, Ter Wee PM, Verhaar MC, Hamaker ME. Quality of life as indicator of poor outcome in hemodialysis: relation with mortality in different age groups. BMC Nephrol. 2017;18:217.","journal-title":"BMC Nephrol"},{"issue":"18","key":"435_CR35","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","volume":"61","author":"DG Jones","year":"2013","unstructured":"Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61(18):1894\u2013903.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"435_CR36","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1540-8159.2005.00270.x","volume":"28","author":"A Berkowitsch","year":"2005","unstructured":"Berkowitsch A, Greiss H, Vukajlovic D, Kuniss M, Neumann T, Zaltsberg S, Kurzidim K, Hamm C, Pitschner HF. Usefulness of atrial fibrillation burden as a predictor for success of pulmonary vein isolation. Pacing Clin Electrophysiol. 2005;28(12):1292\u2013301.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"20","key":"435_CR37","first-page":"e623","volume":"137","author":"LY Chen","year":"2018","unstructured":"Chen LY, Chung MK, Allen LA, Ezekowitz M, Furie KL, McCabe P, Noseworthy PA, Perez MV, Turakhia MP, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular, and Stroke Nursing; Council on Quality of Care, and Outcomes Research;, and Stroke Council. Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association. Circulation. 2018;137(20):e623\u2013e644644.","journal-title":"Circulation"},{"issue":"1","key":"435_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1540-8167.2008.01303.x","volume":"20","author":"Y Khaykin","year":"2009","unstructured":"Khaykin Y, Wang X, Natale A, Wazni OM, Skanes AC, Humphries KH, Kerr CR, Verma A, Morillo CA. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for AF: an economic evaluation of the RAAFT pilot study. J Cardiovasc Electrophysiol. 2009;20(1):7\u201312.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"4","key":"435_CR39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCEP.108.837294","volume":"2","author":"MR Reynolds","year":"2009","unstructured":"Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal AF. Circ Arrhythm Electrophysiol. 2009;2(4):362\u20139.","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00435-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-020-00435-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00435-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:35:52Z","timestamp":1633052152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-020-00435-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1007\/s40256-020-00435-9","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"1 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript. This study was supported by grants from the National Natural Science Foundation of China (nos. 81370285 and 81970206), the Guangdong Natural Science Foundation (2019A1515010269), and the Guangzhou City Science and Technology key program (no. 201508020057) to Dr. Wu. No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Zi-Heng Zheng, Jun Fan, Cheng-Cheng Ji, Yun-Jiu Cheng, Xu-Miao Chen, Jing-Zhou Jiang, and Su-Hua Wu have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No data are available.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"WSH and ZZH made substantial contributions to the design of the present study; ZZH, FJ, JCC, WSH, JJZ, CYJ, CXM analyzed the data; ZZH, FJ, JCC, WSH, CYJ wrote the manuscript. All authors have read and approved the final version of the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}